# From MSCs to iPSCs: building the cell therapy future

Page: https://stenobird.com/podcast/biospace-6696251/from-mscs-to-ipscs-building-the-cell-therapy-future
Text version: https://stenobird.com/podcast/biospace-6696251/from-mscs-to-ipscs-building-the-cell-therapy-future.md
Podcast: [BioSpace](https://stenobird.com/podcast/biospace-6696251)
Published: 2026-05-14T07:00:00+00:00
Episode link: https://api.riverside.com/hosting-analytics/media/e3f666d25e76c7da4d3d0f0c9b9a3216ca9874f751649aba41dcced8868191e7/eyJlcGlzb2RlSWQiOiI5ZGIzNGY2NC1iMTZiLTQwYWQtYjRmZi01NjJmZTUzZDNiZjMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwNGExZGFiMGUyMGEyMDQ0ZGE4YWMwL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTEzX18xOC03LTU0Lm1wMyJ9.mp3
Audio file: https://api.riverside.com/hosting-analytics/media/e3f666d25e76c7da4d3d0f0c9b9a3216ca9874f751649aba41dcced8868191e7/eyJlcGlzb2RlSWQiOiI5ZGIzNGY2NC1iMTZiLTQwYWQtYjRmZi01NjJmZTUzZDNiZjMiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEwNGExZGFiMGUyMGEyMDQ0ZGE4YWMwL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi01LTEzX18xOC03LTU0Lm1wMyJ9.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/from-mscs-to-ipscs-building-the-cell-therapy-future
Duration seconds: 1225

## Resource

In this episode of Denatured, you'll be hearing from Miguel Forte, president of the International Society for Cell and Gene Therapy (ISCT), and John Ellis, co-founder & CEO of Trenchant Bios, speaking live from the ISCT annual meeting. We dive into mesenchymal stem cells and induced pluripotent stem cells, exploring the science behind them, the manufacturing challenges, and the potential for scalable, engineered next-generation therapies. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Jon Ellis , Co-founder & CEO, Trenchant Bio Miguel Forte , President, International Society for Cell & Gene Therapy Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/from-mscs-to-ipscs-building-the-cell-therapy-future/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/biospace-6696251/from-mscs-to-ipscs-building-the-cell-therapy-future.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.